Description

• Highly active against multiple organisms including Staphylococcus aureus, Streptococcus pneumoniae, Haemophilus influenzae & Chlamydia trachomatis.
• Possesses long half life leading to once daily dose convenience
• Improves lung function and increases weight in cystic fibrosis
• Achieves superior clinical cure rates compared to Clarithromycin in chronic bronchitis

In
• Chronic Bronchitis
• Community Acquired Pneumonia
• Tonsillitis & Pharyngitis
• Pneumonia & Bronchitis
• Cystic Fibrosis
• Skin & Soft Tissue Infections
• Typhoid Fever
• Eye Infections
• Bacterial Sinusitis
• Genito Urinary Tract Infections

Maximum action in Deep Infection